Oncology Corporate Profile
Nemucore Medical Innovations, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting multi-drug resistant cancers with a special emphasis on highly lethal women's cancers.
Website: http://www.nemucore.com/
| Brand / Product | Class | Area of Study | Phase | Partnership |
|---|---|---|---|---|
| NMI-900 | aurora kinase inhibitor | Ovarian cancer | II | |
| NMI-900 | aurora kinase inhibitor | Myelodysplastic Syndrome (MDS) | I | |
| NMI-900 | aurora kinase inhibitor | Non Small Cell Lung Cancer (NSCLC) | I | |
| NMI-8000 | aurora kinase inhibitor | Ovarian cancer | I | |
| NMI-300 | aurora kinase inhibitor | Ovarian cancer | I | |
| NMI-500 | aurora kinase inhibitor | Triple negative Breast cancer | I | |
| NMI-900 | aurora kinase inhibitor | Various cancer types | I | |
| NMI-8000 | aurora kinase inhibitor | Various cancer types | I | |
| NMI-300 | aurora kinase inhibitor | Various cancer types | I | |
| NMI-500 | aurora kinase inhibitor | Various cancer types | I |
View additional information on product candidates here »
© Caribou Publishing. All rights reserved. Reproduction in whole or in part is prohibited.
